Spots Global Cancer Trial Database for ifosfamide
Every month we try and update this database with for ifosfamide cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors | NCT01873326 | Germ Cell Tumor... | Paclitaxel Ifosfamide Cisplatin Mesna Bleomycin Etoposide | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia | NCT01331590 | Precursor Cell ... | G-CSF Ifosfamide Etoposide Dexamethasone Mesna | 18 Years - | Washington University School of Medicine | |
| Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma | NCT03719105 | NK-Cell Lymphom... NK-Cell Leukemi... Peripheral T Ce... | Methotrexate pralatraxate, Ifosfamide Dexamethasone Etoposide calaspargase pe... cyclophosphamid... Doxorubicin Prednisone Brentuximab Ved... | 1 Year - 31 Years | New York Medical College | |
| Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia | NCT00040690 | Leukemia Lymphoma | filgrastim cyclophosphamid... cytarabine doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate vincristine sul... radiation thera... | 16 Years - | National Cancer Institute (NCI) | |
| Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer | NCT00004077 | Testicular Germ... | cisplatin ifosfamide paclitaxel | 16 Years - 64 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer | NCT00003941 | Mediastinal Can... Metastatic Canc... Testicular Germ... | bleomycin sulfa... filgrastim cisplatin etoposide ifosfamide bone marrow abl... peripheral bloo... | 16 Years - 50 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS) | NCT00204646 | Sarcoma, Soft T... | Adriamycin Ifosfamide Etoposide Carboplatin | 18 Years - 65 Years | University Hospital Tuebingen | |
| Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma | NCT00072280 | Sarcoma | dactinomycin cyclophosphamid... etoposide ifosfamide vincristine sul... Conventional Su... MESNA (mercapto... Filgrastim | - 2 Years | Children's Oncology Group | |
| Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia | NCT00613457 | Leukemia | dexamethasone asparaginase Asparaginase cyclophosphamid... cytarabine daunorubicin doxorubicin Etoposide Ifosfamide mercaptopurine Methotrexate prednisone thioguanine Vincristine Vindesine | 1 Year - 17 Years | Associazione Italiana Ematologia Oncologia Pediatrica | |
| A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma | NCT00001300 | Sarcoma | doxorubicin ifosfamide mesna | - | National Institutes of Health Clinical Center (CC) | |
| High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors | NCT00936936 | Testicular Canc... | Gemcitabine Docetaxel Melphalan Carboplatin Mesna Ifosfamide Etoposide Stem Cell Trans... | 12 Years - 65 Years | M.D. Anderson Cancer Center | |
| A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma | NCT00667342 | Osteosarcoma Malignant Fibro... | Bevacizumab Cisplatin Doxorubicin Methotrexate Ifosfamide etoposide Surgery Radiotherapy | - 30 Years | St. Jude Children's Research Hospital | |
| Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients | NCT01749072 | Non-small Cell ... Effects of Chem... | Gefitinib group Vinorelbine, If... | 18 Years - 70 Years | Peking Union Medical College Hospital | |
| PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases | NCT02324296 | Small Cell Lung... | ifosfamide | 18 Years - 75 Years | Arcispedale Santa Maria Nuova-IRCCS | |
| PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases | NCT02324296 | Small Cell Lung... | ifosfamide | 18 Years - 75 Years | Arcispedale Santa Maria Nuova-IRCCS | |
| Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors | NCT00274950 | Childhood Germ ... Extragonadal Ge... Ovarian Cancer | bleomycin sulfa... carboplatin cisplatin etoposide ifosfamide vinblastine sul... adjuvant therap... conventional su... | - 17 Years | National Cancer Institute (NCI) | |
| Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma | NCT04776525 | Soft Tissue Sar... | Ifosfamide Doxorubicin | 18 Years - | Oslo University Hospital | |
| Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma | NCT03458260 | Aggressive Non-... | Pixantrone Ifosfamide Etoposide Rituximab Transplant | 18 Years - | The Lymphoma Academic Research Organisation | |
| Fosaprepitant in Patients Receiving Ifosfamide-based Regimen | NCT01490060 | Sarcoma Chemotherapy-in... Effects of Chem... Adverse Effects... | Fosaprepitant Dexamethasone 5HT3 receptor a... Ifosfamide-base... Doxorubicin Mesna Ifosfamide Vincristine | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors | NCT00502892 | Solid Tumors | Topotecan Ifosfamide Carboplatin | - 45 Years | M.D. Anderson Cancer Center | |
| Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment | NCT02812654 | Sarcoma, Soft T... | Doxorubicin Ifosfamide radiotherapy | 18 Years - 75 Years | AC Camargo Cancer Center | |
| Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | NCT00003240 | Lung Cancer | cisplatin ifosfamide mitomycin C vinblastine sul... vindesine vinorelbine tar... conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma | NCT00193505 | Non-Hodgkins Ly... | Ifosfamide Carboplatin Etoposide Rituximab 90Y Zevalin | 18 Years - | SCRI Development Innovations, LLC | |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | NCT00002764 | Endometrial Can... Kidney Cancer Metastatic Canc... Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide conventional su... | 16 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus | NCT00002546 | Sarcoma | cisplatin ifosfamide adjuvant therap... radiation thera... | 21 Years - 120 Years | GOG Foundation | |
| Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment | NCT00324467 | Lymphoma, Non-H... Advanced Stage ... | Cyclophosphamid... Doxorubicin Vincristine Prednisone Ondansetron Dexamethasone Diphenhydramine Acetaminophen Ifosfamide Mesna (IV) Mesna (oral) Carboplatin Etoposide Rituximab Ondansetron Dexamethasone Diphenhydramine Acetaminophen PET Scan | 18 Years - | British Columbia Cancer Agency | |
| Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma | NCT00645632 | Sarcoma | cisplatin doxorubicin hyd... ifosfamide methotrexate adjuvant therap... neoadjuvant the... therapeutic con... | - | Mayo Clinic | |
| Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma | NCT00007865 | Lymphoma | rituximab carboplatin etoposide ifosfamide | 19 Years - 120 Years | University of Nebraska | |
| Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma | NCT00410631 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide phosp... ifosfamide isotretinoin melphalan topotecan hydro... vincristine sul... vindesine autologous hema... conventional su... peripheral bloo... iobenguane I 13... radiation thera... | - 21 Years | National Cancer Institute (NCI) | |
| A Study to Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy | NCT04044222 | Classic Hodgkin... | Sintilimab Carboplatin Etoposide Ifosfamide Placebo Carboplatin Etoposide Ifosfamide | 18 Years - | Innovent Biologics (Suzhou) Co. Ltd. | |
| Combination Chemotherapy in Treating Patients With Lymphoma | NCT00002835 | Lymphoma | Bleomycin Sulfa... Filgrastim (G-C... Recombinant Int... Carmustine Cisplatin (CDDP... Cyclophosphamid... Cytarabine (ARA... Etoposide (VP-1... Idarubicin Ifosfamide Leucovorin Calc... Melphalan Methotrexate Methylprednisol... mitoxantrone hy... Vincristine Sul... Peripheral Bloo... Radiation Thera... | 15 Years - 59 Years | M.D. Anderson Cancer Center | |
| Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICE | NCT02686346 | Hodgkin Disease | Brentuximab Ved... Etoposide Carboplatine Ifosfamide | 18 Years - 65 Years | The Lymphoma Academic Research Organisation | |
| Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | NCT00002697 | Lymphoma | filgrastim sargramostim carboplatin etoposide ifosfamide autologous bone... bone marrow abl... peripheral bloo... radiation thera... | 18 Years - 65 Years | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain | NCT00293358 | Brain and Centr... | carboplatin cisplatin etoposide phosp... ifosfamide adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - | National Cancer Institute (NCI) | |
| Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma | NCT00439361 | Hodgkin Lymphom... Lymphoma | Bortezomib Carboplatin Etoposide Ifosfamide Mesna | 16 Years - | M.D. Anderson Cancer Center | |
| Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma | NCT00334854 | Childhood Malig... Sarcoma | doxorubicin hyd... ifosfamide adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - 20 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma | NCT00255723 | Lymphoma | carboplatin etoposide ifosfamide | 18 Years - 72 Years | Memorial Sloan Kettering Cancer Center | |
| Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | NCT00017225 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide ifosfamide melphalan tretinoin vincristine sul... vindesine autologous bone... conventional su... peripheral bloo... radiation thera... | - 20 Years | National Cancer Institute (NCI) | |
| A Study of N9 Chemotherapy in Children With Neuroblastoma | NCT04947501 | Neuroblastoma Pediatric Cance... | Cyclophosphamid... Topotecan Vincristine Doxorubicin Ifosfamide Etoposide Carboplatin Mesna | 1 Year - 19 Years | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors | NCT03628131 | Relapsed Pediat... Refractory Pedi... | Pazopanib Ifosfamide Carboplatin Etoposide | 2 Years - 22 Years | Samsung Medical Center | |
| Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma | NCT00822848 | Sarcoma | epirubicin hydr... ifosfamide sorafenib tosyl... immunoenzyme te... immunohistochem... laboratory biom... adjuvant therap... neoadjuvant the... therapeutic con... hypofractionate... | 15 Years - 120 Years | OHSU Knight Cancer Institute | |
| A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma | NCT04154189 | Osteosarcoma | Lenvatinib Ifosfamide Etoposide Lenvatinib | 2 Years - 25 Years | Eisai Inc. | |
| TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer | NCT04475016 | Penile Cancer | Albumin-Bound P... Ifosfamide Cisplatin Nimotuzumab Triprilimab | 18 Years - 75 Years | Sun Yat-sen University | |
| Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin | NCT00002559 | Ovarian Cancer Testicular Germ... | filgrastim cisplatin ifosfamide paclitaxel | 15 Years - | Memorial Sloan Kettering Cancer Center | |
| A Study of N9 Chemotherapy in Children With Neuroblastoma | NCT04947501 | Neuroblastoma Pediatric Cance... | Cyclophosphamid... Topotecan Vincristine Doxorubicin Ifosfamide Etoposide Carboplatin Mesna | 1 Year - 19 Years | Memorial Sloan Kettering Cancer Center | |
| Idelalisib With Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) in Children and Adolescents | NCT03349346 | Diffuse Large B... Mediastinal B-c... | Idelalisib Rituximab Ifosfamide Carboplatin Etoposide | 1 Year - 18 Years | Gilead Sciences | |
| Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma | NCT00742924 | Sarcoma | cisplatin dexrazoxane hyd... doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate zoledronic acid adjuvant therap... neoadjuvant the... therapeutic con... filgrastim Mesna | - 40 Years | Children's Oncology Group | |
| R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma | NCT02628405 | Recurrent B-Cel... Recurrent Diffu... Recurrent Prima... Recurrent Trans... Refractory B-Ce... Refractory Diff... Refractory Prim... Refractory Tran... | Carboplatin Etoposide Ifosfamide Laboratory Biom... Lenalidomide Rituximab | 18 Years - | Academic and Community Cancer Research United | |
| An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS) | NCT00796120 | Sarcoma | Trabectedin Doxorubicin Ifosfamide | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma | NCT00346125 | Sarcoma | pegfilgrastim doxorubicin hyd... ifosfamide pegylated lipos... conventional su... fludeoxyglucose... | 16 Years - | Masonic Cancer Center, University of Minnesota | |
| Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy | NCT00673179 | Osteosarcoma | Doxorubicin Cisplatin Methotrexate Leucovorin Dexrazoxane Ifosfamide Questionnaire Gemcitabine Sargramostim Surgery Mesna | 5 Years - 40 Years | M.D. Anderson Cancer Center | |
| Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery | NCT00652860 | Metastatic Canc... Sarcoma | aerosol sargram... sargramostim cisplatin doxorubicin hyd... ifosfamide mitomycin C flow cytometry immunological d... laboratory biom... adjuvant therap... multimodality t... neoadjuvant the... therapeutic con... intraoperative ... selective exter... | 18 Years - | Mayo Clinic | |
| Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma | NCT00274924 | Lymphoma | filgrastim rituximab carboplatin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide prednisone vincristine | 18 Years - 70 Years | Eastern Cooperative Oncology Group | |
| Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma | NCT00126191 | Burkitt Lymphom... Non-Hodgkins Ly... Atypical Burkit... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Methotrexate Leucovorin Ifosfamide Etoposide Cytarabine Mesna | 18 Years - | Dana-Farber Cancer Institute | |
| MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma | NCT06277154 | Leiomyosarcoma Liposarcoma Synovial Sarcom... Angiosarcoma Undifferentiate... Epithelioid Sar... Malignant Perip... Fibrosarcoma Pleomorphic Rha... Endometrial Str... Desmoplastic Sm... | MASCT-I Doxorubicin Ifosfamide | 18 Years - 70 Years | HRYZ Biotech Co. | |
| Ibrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma | NCT02219737 | CD20 Positive Recurrent Diffu... Refractory Diff... | Carboplatin Etoposide Ibrutinib Ifosfamide Laboratory Biom... Pharmacological... Rituximab | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia | NCT00002494 | Leukemia Lymphoma | cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide ifosfamide leucovorin calc... mesna methotrexate prednisone therapeutic hyd... vincristine sul... low-LET cobalt-... low-LET photon ... | 15 Years - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia | NCT00040690 | Leukemia Lymphoma | filgrastim cyclophosphamid... cytarabine doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate vincristine sul... radiation thera... | 16 Years - | National Cancer Institute (NCI) | |
| Idelalisib With Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) in Children and Adolescents | NCT03349346 | Diffuse Large B... Mediastinal B-c... | Idelalisib Rituximab Ifosfamide Carboplatin Etoposide | 1 Year - 18 Years | Gilead Sciences | |
| Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma | NCT02808247 | Sarcoma, Soft T... | Nintedanib Ifosfamide | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia | NCT00002532 | Leukemia | filgrastim asparaginase cytarabine daunorubicin hy... dexamethasone etoposide idarubicin ifosfamide leucovorin calc... methotrexate prednisolone vindesine | 15 Years - 65 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer | NCT00002822 | Lung Cancer | carboplatin cisplatin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide mesna vincristine sul... radiation thera... | - | National Cancer Institute (NCI) | |
| AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | NCT00147225 | Solid Tumors Advanced Cancer | AMG 531 Carboplatin Adriamycin Ifosfamide | 18 Years - | M.D. Anderson Cancer Center | |
| Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma | NCT04824352 | Effect of Drug Toxicity, Drug | apatinib | 12 Years - 70 Years | Peking University People's Hospital | |
| Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma | NCT00003776 | Sarcoma | filgrastim cisplatin doxorubicin hyd... ifosfamide leucovorin calc... methotrexate trimetrexate gl... surgical proced... | - 30 Years | Memorial Sloan Kettering Cancer Center | |
| New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement | NCT02329080 | Diffuse Large B... | Methotrexate Rituximab Cytarabine Thiotepa liposomial cyta... Etoposide Ifosfamide Carmustine whole brain rad... | 18 Years - 70 Years | International Extranodal Lymphoma Study Group (IELSG) | |
| Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma | NCT00003541 | Lymphoma | filgrastim CHOP regimen carboplatin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide prednisone vincristine sul... peripheral bloo... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | NCT00147225 | Solid Tumors Advanced Cancer | AMG 531 Carboplatin Adriamycin Ifosfamide | 18 Years - | M.D. Anderson Cancer Center | |
| A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer | NCT00060944 | Liposarcoma Leiomyosarcoma | Yondelis Yondelis Dexamethasone Dexamethasone | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors | NCT02375204 | Germ Cell Tumor Teratoma Choriocarcinoma Germinoma Mixed Germ Cell... Yolk Sac Tumor Childhood Terat... Malignant Germ ... Extragonadal Se... Non-seminomatou... Seminoma | paclitaxel ifosfamide cisplatin pegylated G-CSF G-CSF carboplatin etoposide phosp... stem cell reinf... | 14 Years - | Alliance for Clinical Trials in Oncology | |
| Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme) | NCT02408042 | Lymphoma Hodgkin's Lymph... Non-hodgkin's L... | Pembrolizumab Etoposide Ifosfamide Mesna Carboplatin Brentuximab ved... Rituximab | 18 Years - | Western Regional Medical Center | |
| Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma | NCT00003937 | Cardiac Toxicit... Sarcoma | cisplatin dexrazoxane hyd... doxorubicin hyd... etoposide ifosfamide methotrexate conventional su... | - 30 Years | Children's Oncology Group | |
| Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma | NCT00002565 | Lymphoma | bleomycin sulfa... CHOP regimen cisplatin cyclophosphamid... cytarabine doxorubicin hyd... etoposide idarubicin ifosfamide mesna methylprednisol... mitoxantrone hy... prednisone vincristine sul... | 15 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas | NCT00278278 | Brain and Centr... | cisplatin etoposide ifosfamide lomustine methotrexate prednisone vincristine sul... | 3 Years - 18 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas | NCT03071822 | Peripheral T Ce... | cisplatin ifosfamide gemcitabine L-asparaginase etoposide dexamethasone | 18 Years - 80 Years | The University of Hong Kong | |
| Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma | NCT01884428 | Hodgkin's Lymph... | panobinostat Ifosfamide Gemcitabine Vinorelbine Prednisolone | 18 Years - 65 Years | Istituto Clinico Humanitas | |
| International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) | NCT02305654 | Squamous Cell C... | ILND - Inguinal... Paclitaxel Ifosfamide Cisplatin Intensity modul... Prophylactic PL... | 18 Years - | Institute of Cancer Research, United Kingdom | |
| Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma | NCT00974792 | Lymphoma | pegfilgrastim rituximab cyclophosphamid... cytarabine doxorubicin hyd... etoposide phosp... ifosfamide leucovorin calc... methotrexate vincristine sul... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma | NCT03514381 | Soft Tissue Sar... | Patients starti... | 18 Years - | Institut Claudius Regaud | |
| International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry | NCT01464606 | Pleuropulmonary... | Vincristine Dactinomycin Cyclophosphamid... Ifosfamide Doxorubicin | - 21 Years | Children's Hospitals and Clinics of Minnesota |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
